Download - Methodenwebinare

Evidence Identification in Systematic Reviews

Dr. Michael Gusenbauer

(Post-Doc Researcher, University of Innsbruck)

Rapid Review Methods - current insights

Dr. Barbara Nußbaumer-Streit, MSc BSc Bakk

(Donau-Universität Krems)

Influence of different mortality time points on pooled effect estimates

Dominik Roth (Medizinische Universität Wien)

What Makes Realist Reviews Realist? - A Rapid-Fire Introduction

Gill Westhorp, PhD (Professorial Research Fellow at Charles Darwin University)

Definition of the Fragility Index of meta-analyses

Ignacio Atal, PhD (Center for Research and Interdisciplinarity (CRI) , Université de Paris, INSERM U1284)

^{Plublikation: Atal I, Porcher R, Boutron I, Ravaud P. The statistical significance of meta-analyses is frequently fragile: definition of a fragility index for meta-analyses. J Clin Epidemiol 2019;111:32-40. doi: https://doi.org/10.1016/j.jclinepi.2019.03.012}

^{Link zum Webtool: http://clinicalepidemio.fr/fragility_ma/}

Cochrane's Dissemination Checklist: Methods for effectively sharing your review results

Stephanie Lagosky (Knowledge Translation Project Officer at Cochrane)

Guidance for identifying trial participants with missing data

Lara Kahale (American University of Beirut medial Center)

The PRISMA 2020 statement: an updated guideline for reporting systematic reviews

Dr. Matthew Page, PhD (Senior Research Fellow and ARC DECRA Fellow from Monash University in Melbourne, Australia)

Cochrane RoB 2.0

Dr. Jelena Savovic (University of Bristol)

The GRADE Working Group clarifies the construct of certainty of evidence

Univ. Prof. Dr. Gerald Gartlehner, MPH (Donau-Universität Krems)

Developing trust worthy guidelines for tests and diagnostic strategies using the GRADE approach

Reem Mustafa, MD FACP MPH PhD (Associate professor of Medicine, Division of Nephrology and Hypertension)

Challenges in Assessing Adverse Effects

Yoon Loke

(Professor of Medicine and Pharmacology, Norwich Medical School, University of East Anglia, UK)

Logic models in systematic reviews

Prof. Eva Rehfuess

(Chair of Public Health and Health Service Research Pettenkofer School of Public Health (PSPH) Institute for Medical Information Processing, Biometry and Epidemiology)

Tool to Address Conflicts of Interest in Trials

Asbjorn Hrobjartsson

(Nordic Cochrane Center, senior researcher)

GRADE - CERQual

Dr. Claire Glenton (Cochrane Norway)

Living Systematic Reviews

Elie Akl, MD MPH PhD (American University of Beirut)

Software Robot Analyst

Prof. Sophia Ananiadou (University of Manchester)

Recommendations for Assessing the Risk of Bias in Systematic Reviews of Health Care Interventions

Meera Viswanathan, PhD (RTI International)

Evaluating three semi-automated sreening tools (RobotAnalyst, Abstrackr and Rayyan) for systematic reviews. Can we solve workload?

Dr.ⁱⁿ Nina Matyas

Cochrane Classmate

Anna Noel-Storr (University of Oxford, Radcliff Department of Medicine)

U.S. Department of Veterans Affairs Evidence-based Synthesis Program Coordinating Center Rapid Review Program

Kimberly Peterson, MS (Research Associate, OSHU; Pacific Northwest Evidence-based Practice Center)

PRISMA - Complex Interventions

Meera Viswanathan, PhD (RTI International)

Behaviour Change Techniques and Theories: How to analyse the content and mechanism of action of behaviour change interventions in published articles?

Prof. Susan Michie (University College London)

Use of Qualitative Comparative Analysis in Systematic Rewies: Examples and Lessons Learned

Leila C. Kahwati, MD MPH (RTI International)

Risk of bias for observational or exposure studies

Meera Viswanathan, PhD (RTI International)

MAGICapp for evidence synthesizers in an emerging Trustworthy and Digital Evidence Ecosystem

Per Olav Vandvik, MD PhD (University of Oslo, Faculty of Medicine)

Cancer Screening and Overdiagnosis Problems posed by Birds, Rabbits and Turtles

H.Gilbert Welch, MD MPH (The Dortmouth Insitute)

Interrupted time series (ITS) and controlled before-after (CBA) studies

Stephanie Polus, MPH (Ludwig-Maximillians-Universität München)

Introduction to Covidence

Anneliese Arno (Covidence Dublin)

Rapid Reviews

Julie Polisena und Chris Kamel (Canadian Agency for Drugs and Technologies in Health)

I², Tau², Calculating prediction intervals

Dr. Michael Borenstein (Biostad)

Is GRADE better than horoscopes to predict the stability of treatment effects?

Univ.-Prof. Dr. Gerald Gartlehner, MPH (Danube University Krems)

PROBAST

Robert Wolf, M.D. (Kleijnen Systematic Reviews Ltd)